Education
About Us
Working with TipRanks
Follow Us
Medacta Group Sa (CH:MOVE)
:MOVE
MOVE Analyst Ratings
Strong Buy
3 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MOVE Stock 12 Month Forecast
Average Price Target
CHF153.33
▲(2.91% Upside)
| Highest Price TargetCHF160.00 | Average Price TargetCHF153.33 | Lowest Price TargetCHF141.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
CHF167
Buy
12.08%
Upside
Upgraded
08/01/25
Medacta Group SA's strong financial performance, characterized by robust revenue growth and profitability, is the primary driver of the stock score. Technical analysis supports a favorable short-term outlook despite overbought signals. However, the high P/E ratio raises concerns about valuation, and limited dividend yield contributes little to investor income.
Morgan Stanley
CHF146→CHF159
Buy
6.71%
Upside
Reiterated
08/01/25
UBS
CHF141
Buy
-5.37%
Downside
Reiterated
08/01/25
Berenberg Bank
CHF160
Buy
7.38%
Upside
Reiterated
07/02/25
Stifel Nicolaus
CHF142
Buy
-4.70%
Downside
Reiterated
03/25/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
CHF167
Buy
12.08%
Upside
Upgraded
08/01/25
Medacta Group SA's strong financial performance, characterized by robust revenue growth and profitability, is the primary driver of the stock score. Technical analysis supports a favorable short-term outlook despite overbought signals. However, the high P/E ratio raises concerns about valuation, and limited dividend yield contributes little to investor income.
Morgan Stanley
CHF146→CHF159
Buy
6.71%
Upside
Reiterated
08/01/25
UBS
CHF141
Buy
-5.37%
Downside
Reiterated
08/01/25
Berenberg Bank
CHF160
Buy
7.38%
Upside
Reiterated
07/02/25
Stifel Nicolaus
CHF142
Buy
-4.70%
Downside
Reiterated
03/25/25
Best Analysts Covering Medacta Group SA
1 Month
xxx
Success Rate
4/4 ratings generated profit
Average Return
+6.45%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +6.45% per trade.
3 Months
xxx
Success Rate
4/4 ratings generated profit
Average Return
+7.63%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +7.63% per trade.
1 Year
Success Rate
4/4 ratings generated profit
Average Return
+24.68%
reiterated a buy rating 7 days ago
Copying Aisyah Noor's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +24.68% per trade.
2 Years
xxx
Success Rate
5/5 ratings generated profit
Average Return
+30.22%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +30.22% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MOVE Analyst Recommendation Trends
Rating
Mar 25
Apr 25
Jun 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
0
Buy
5
5
3
2
4
Hold
0
0
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
5
4
6
Each month's total comprises the sum of three months' worth of ratings.
MOVE Financial Forecast
MOVE Stock Forecast FAQ
What is CH:MOVE’s average 12-month price target, according to analysts?
Based on analyst ratings, Medacta Group Sa’s 12-month average price target is 153.33.
What is CH:MOVE’s upside potential, based on the analysts’ average price target?
Medacta Group Sa has 2.91% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Medacta Group Sa a Buy, Sell or Hold?
Medacta Group Sa has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Medacta Group Sa’s share price target?
The average share price target for Medacta Group Sa is 153.33. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF160.00 ,and the lowest forecast is CHF141.00. The average share price target represents 2.91% Increase from the current price of CHF149.
The highest analyst share price target is CHF160.00 ,and the lowest forecast is CHF141.00. The average share price target represents 2.91% Increase from the current price of CHF149.
What do analysts say about Medacta Group Sa?
Medacta Group Sa’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of Medacta Group Sa?
To buy shares of CH:MOVE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.